JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prasad, K. N.
Right arrow Articles by Cole, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prasad, K. N.
Right arrow Articles by Cole, W. C.
Journal of the American College of Nutrition, Vol. 22, No. 2, 108-117 (2003)
Published by the American College of Nutrition


Review Article

{alpha}-Tocopheryl Succinate, the Most Effective Form of Vitamin E for Adjuvant Cancer Treatment: A Review

Kedar N. Prasad, PhD, Bipin Kumar, MD, Xiang-Dong Yan, MD, Amy J. Hanson, MS and William C. Cole, PhD

Center for Vitamins and Cancer Research, Department of Radiology, University of Colorado Health Sciences Center, Denver, Colorado

Address reprint requests to: Kedar N. Prasad, Ph.D., Campus Box C-278, UCHSC, 4200 E. 9th Ave. Denver, CO 80262. E-mail: Kedar.Prasad{at}UCHSC.edu

In 1982, it was established that alpha-tocopheryl succinate ({alpha}-TS) was the most effective form of vitamin E in comparison to {alpha}-tocopherol, {alpha}-tocopheryl acetate and {alpha}-tocopheryl nicotinate in inducing differentiation, inhibition of proliferation and apoptosis in cancer cells, depending upon its concentration. During the last two decades, several studies have confirmed this observation in rodent and human cancer cells in culture and in vivo (animal model). The most exciting aspect of this {alpha}-TS effect is that it does not affect the proliferation of most normal cells. In spite of several studies published on the anti-cancer properties of {alpha}-TS, the value of this form of vitamin E has not drawn significant attention from researchers and clinicians. Therefore, a critical review on the potential role of {alpha}-TS in the management of cancer is needed. In addition, such a review can also provide in-depth analysis of existing literature on this subject. {alpha}-TS treatment causes extensive alterations in gene expression; however, only some can be attributed to differentiation, inhibition of proliferation and apoptosis. {alpha}-TS also enhances the growth-inhibitory effect of ionizing radiation, hyperthermia, some chemotherapeutic agents and biological response modifiers on tumor cells, while protecting normal cells against some of their adverse effects. Thus, {alpha}-TS alone or in combination with dietary micronutrients can be useful as an adjunct to standard cancer therapy by increasing tumor response and possibly decreasing some of the toxicities to normal cells.

Key words: {alpha}-tocopheryl succinate, cancer, gene expressions, differentiation, growth inhibition, apoptosis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Nutrition.